Leone Patterson

Ms. Patterson is Chief Financial and Business Officer of Tenaya Therapeutics, a publicly-traded clinical-stage biotechnology company focused on cardiovascular disease.

Prior to Tenaya, Ms. Patterson served as the President and Chief Financial Officer of Adverum Biotechnologies, Inc. and formerly held the positions of Chief Executive Officer and Director. Previously, Ms. Patterson as Chief Financial Officer at Diadexus, Inc. and Transcept Pharmaceuticals, Inc. until its acquisition by Paratek Pharmaceuticals, Inc. Earlier in her career, she served in financial leadership roles at NetApp, Inc., Exelixis, Inc., Novartis AG, and Chiron.

Ms. Patterson earned a B.S. in Business Administration and Accounting from Chapman University and an Executive M.B.A. from St. Mary’s College. Ms. Patterson is also a Certified Public Accountant (inactive status).